 
      
      Thinking About Risk: Devin Rosenthal, PhD, MBA
Learning about how Devin and his firm think about risk in biotech.
 
      
      Drug Money: Michigan Therapeutics Companies & Financing 2009-2019
A second dive into the Michigan drug development ecosystem.